University of Michigan, Pediatric Hematology and Oncology

Ann Arbor, Michigan 48109-5718

1 studies enrolling now · 2 studies all time

What they study most

Hemophilia A

Studies at this site

• A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401) — Enrolling by invitation
• Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301) — Completed